SE454699B - Peptider och lekemedel innehallande desamma - Google Patents

Peptider och lekemedel innehallande desamma

Info

Publication number
SE454699B
SE454699B SE8107634A SE8107634A SE454699B SE 454699 B SE454699 B SE 454699B SE 8107634 A SE8107634 A SE 8107634A SE 8107634 A SE8107634 A SE 8107634A SE 454699 B SE454699 B SE 454699B
Authority
SE
Sweden
Prior art keywords
mixture
group
acid
under reduced
reduced pressure
Prior art date
Application number
SE8107634A
Other languages
English (en)
Swedish (sv)
Other versions
SE8107634L (sv
Inventor
J Bouchaudon
G Dutruc-Rosset
D Farge
C James
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of SE8107634L publication Critical patent/SE8107634L/
Publication of SE454699B publication Critical patent/SE454699B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8107634A 1980-12-19 1981-12-18 Peptider och lekemedel innehallande desamma SE454699B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8027020A FR2496654A1 (fr) 1980-12-19 1980-12-19 Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
SE8107634L SE8107634L (sv) 1982-06-20
SE454699B true SE454699B (sv) 1988-05-24

Family

ID=9249292

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8107634A SE454699B (sv) 1980-12-19 1981-12-18 Peptider och lekemedel innehallande desamma

Country Status (17)

Country Link
US (1) US4401658A (fr)
JP (1) JPS57154151A (fr)
AU (1) AU555294B2 (fr)
BE (1) BE891539A (fr)
CA (1) CA1250398A (fr)
CH (1) CH653039A5 (fr)
DE (1) DE3150295A1 (fr)
DK (1) DK154436C (fr)
FR (1) FR2496654A1 (fr)
GB (1) GB2089816B (fr)
IE (1) IE52113B1 (fr)
IT (1) IT1142148B (fr)
LU (1) LU83843A1 (fr)
NL (1) NL8105587A (fr)
NZ (1) NZ199310A (fr)
SE (1) SE454699B (fr)
ZA (1) ZA818737B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5019383A (en) * 1981-01-09 1991-05-28 New York Blood Center, Inc. Fatty acid carriers for synthetic peptides
US6074650A (en) * 1985-06-24 2000-06-13 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
US6024964A (en) * 1985-06-24 2000-02-15 Hoechst Aktiengesellschaft Membrane anchor/active compound conjugate, its preparation and its uses
WO1988001613A1 (fr) * 1986-08-27 1988-03-10 Pfizer Inc. N-(s-3-methylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine cristalline, procedes de production et produits intermediaires pour son obtention
WO1988001612A1 (fr) * 1986-08-27 1988-03-10 Pfizer Inc. Procedes de production et produits intermediaires de n-(s-3-alkylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
US4874608A (en) * 1987-04-27 1989-10-17 Imreg, Inc. Therapeutic method for treating malignancies
US5721109A (en) * 1989-01-18 1998-02-24 Sawai Pharmaceutical Co., Ltd. Method for diagnosing infection caused by acid-fast bacterium
EP0407605B1 (fr) * 1989-01-18 1995-09-13 Sawai Pharmaceutical Co., Ltd. Utilisation d'un reactif pour la detection d'un anticorps correspondant a un antigene de bacterie resistante a l'acide
US5134225A (en) * 1989-02-21 1992-07-28 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-D-alanine
US5185464A (en) * 1989-02-21 1993-02-09 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5245079A (en) * 1989-02-21 1993-09-14 Pfizer Inc. Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
US5248820A (en) * 1989-02-21 1993-09-28 Pfizer Inc. Crystalline N-(S-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
US5136020A (en) * 1989-02-21 1992-08-04 Pfizer Inc. Crystalline n-(s-3-methylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine, and processes and intermediates therefor
DE9110182U1 (de) * 1991-08-17 1992-12-17 Wilhelm Koch GmbH, 4830 Gütersloh Einbauleuchte
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
KR101219880B1 (ko) * 2010-10-08 2013-01-08 한국생산기술연구원 나노 버블을 이용한 두부제조방법
WO2012142659A1 (fr) * 2011-04-19 2012-10-26 Baker Idi Heart And Diabetes Institute Holdings Limited Modification de protéines avec sélectivité de site
EP2975046A1 (fr) * 2014-07-16 2016-01-20 The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth Nouveaux composés
CN110092735B (zh) * 2018-01-31 2021-05-11 尚科生物医药（上海）有限公司 一种l-丙氨酸衍生物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
EP0011283B1 (fr) * 1978-11-14 1982-07-28 Fujisawa Pharmaceutical Co., Ltd. Lactyl-tétrapeptide, procédé pour sa préparation et compositions pharmaceutiques le contenant
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
FR2460289A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent

Also Published As

Publication number Publication date
FR2496654B1 (fr) 1983-12-16
BE891539A (fr) 1982-06-18
GB2089816B (en) 1984-07-18
US4401658A (en) 1983-08-30
IT8125703A0 (it) 1981-12-18
NL8105587A (nl) 1982-07-16
CH653039A5 (fr) 1985-12-13
AU555294B2 (en) 1986-09-18
LU83843A1 (fr) 1982-07-07
IE52113B1 (en) 1987-06-24
DK563181A (da) 1982-06-20
GB2089816A (en) 1982-06-30
ZA818737B (en) 1982-11-24
DE3150295A1 (de) 1982-07-29
JPH0337560B2 (fr) 1991-06-05
NZ199310A (en) 1985-10-11
FR2496654A1 (fr) 1982-06-25
SE8107634L (sv) 1982-06-20
DK154436C (da) 1989-04-17
IT1142148B (it) 1986-10-08
IE812974L (en) 1982-06-19
DK154436B (da) 1988-11-14
CA1250398A (fr) 1989-02-21
AU7859081A (en) 1982-06-24
JPS57154151A (en) 1982-09-22

Similar Documents

Publication Publication Date Title
SE454699B (sv) Peptider och lekemedel innehallande desamma
KR870000372B1 (ko) 아실트리펩타이드의 제조방법
RU2007396C1 (ru) Способ получения n-карбоксиангидридов или n-тиокарбоксиангидридов уретанзащищенных аминокислот
US4742048A (en) Tetrapeptides and pentapeptides, their preparation and compositions containing them
DE3786250T2 (de) Phosphinsäure-Derivate.
CA2070331A1 (fr) Peptides et pseudopeptides derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA1318457C (fr) Analogues de la tuftisine partiellement retro-invertis, methode pour leur preparation et compositions pharmaceutiques en contenant
US4298523A (en) Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R
US5504189A (en) Peptides, their preparation and use
JPS63250360A (ja) サイモペンチンレトロ−インバーソ類似体及びそのフラグメント
GB2127830A (en) Amides of tripeptides and tetrapeptides
US4362716A (en) Dipeptides, their preparation and compositions containing them
KR900003515B1 (ko) 헵타노일-glu-asp-ala-아미노산 면역자극물질
HU185229B (en) Process for preparing pharmaceutically active peptides and acetates thereof
US5089476A (en) Glutamic acid derivatives
NL8003761A (nl) Tripeptiden, werkwijze ter bereiding ervan, alsmede farmaceutische preparaten die de tripeptiden bevatten.
GB1587427A (en) Polypeptide derivatives
US3433779A (en) Long-chain aliphatic esters of lysine and other basic amino acids and peptides thereof
FR2543546A1 (fr) Derives de gonadoreline contenant un groupe b-aspartyle, procede pour leur preparation et preparations pharmaceutiques les contenant
US4247543A (en) Organic compounds
CA1156220A (fr) Methode et composition pour la preparation de h-sar-lys-sar-gln-nh.sub.2
Katakai et al. Peptide synthesis using o‐nitrophenylsulfenyl N‐carboxy α‐amino acid anhydrides. Sequential oligopeptides having alternate γ‐methyl l‐glutamyl and l‐phenylalanyl residues
EP0406931B1 (fr) Analogues de la thymopentine avec toutes les liaisons rétro-inverties, leur méthode de préparation et leur utilisation pour la préparation de compositions pharmaceutiques
KR900004648B1 (ko) 펩타이드 유도체의 제조방법
KR820001094B1 (ko) 펜타펩타이드의 제조방법

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8107634-1

Effective date: 19930709

Format of ref document f/p: F